HIV Women's Health: A Study of Gynecological Healthcare Service Utilization in a U.S. Urban Clinic Population

Abstract

Background:

Women infected with HIV have a high rate of many gynecological problems. Adherence to recommended gynecological care among women enrolled in our urban HIV clinics was hypothesized to be low.

Methods:

We conducted an analysis of data from the Johns Hopkins HIV Clinical Cohort Database examining demographic and clinical predictors of clinic visit adherence by women in the HIV primary care and HIV gynecological clinics.

Results:

Between January 2002 and April 2006, 1,086 women had 26,401 scheduled appointments to the two clinics, of which 21,959 were to HIV primary care and 4,442 were to HIV gynecological care. There were 12,097 (55%) completed primary care visits and 1,609 (36.2%) completed HIV gynecological visits (p < 0.001, accounting for clustering). By multivariate analysis, age <40 years (OR 0.81, 95% CI 0.70-0.94) and substance abuse (OR 0.67, 95% CI 0.61-0.73) were associated with a decreased likelihood of attending an HIV primary care appointment. African American race (OR 0.63, 95% CI 0.45-0.90), CD4 count <200 cells/mm³ (OR 0.73, 95% CI 0.56-0.95), and substance abuse (OR 0.57, 95% CI 0.45-0.71) were associated with a decreased likelihood of attending an HIV gynecological appointment.

Conclusions:

This analysis determined that the rate of clinic visit adherence is significantly lower for HIV gynecological care than for HIV primary care in the same population of women. Factors associated with HIV gynecological clinic visit noncompliance included African American race/ethnicity, substance use, and more advanced immunosuppression. We have planned additional quantitative and qualitative studies to examine the associations with and barriers to HIV gynecological care, with the goal of creating appropriate interventions toward improving gynecological healthcare utilization among women enrolled in urban HIV clinics.

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention (CDC) Divisions of HIV/AIDS Prevention. HIV/AIDS among women. Department of Health and Human Services June 2007. www.cdc.gov/hiv/topics/women/resources/factsheets/women.htm.

Maryland Department of Health and Mental Hygiene (MDHMH) AIDS Administration. 2005 HIV/AIDS annual report. www.dhmh.state.md.us/AIDS/Data&Statistics/statistics.htm.

Frankel

, Selwyn

, Mezger

, Andrews

. High prevalence of gynecologic disease among hospitalized women with human immunodeficiency virus infection. Clin Infect Dis, 1997; 25:706–712.

Korn

. Gynecologic care of women infected with HIV. Clin Obstet Gynecol, 2001; 44:226–242.

Cejtin

. Gynecologic issues in the HIV-infected woman. Obstet Gynecol Clin North Am, 2003; 30:711–729.

Jamieson

, Paramsothy

, Cu-Uvin

, Duerr

. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for HIV. Obstet Gynecol, 2006; 107:1023–1028.

Uphold

, Mkanta

. Review: Use of health care services among persons living with HIV infection: State of the science and future directions. AIDS Patient Care STDs, 2005; 19:473–485.

Lachance

, Everett

, Greer

et al. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol, 2006; 101:470–475.

Gichangi

, De Vuyst

, Estambale

et al. HIV and cervical cancer in Kenya. Int J Gynecol Obstet, 2002; 76:55–63.

10.

Smith

, Saslow

, Sawyer

et al. American Cancer Society screening guidelines for breast cancer screening: Update 2003. CA Cancer J Clin, 2003; 53:141–169.

11.

Minkoff

, Eisenberger-Matityahu

, Feldman

, Burk

, Clark

. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol, 1999; 180:824–836.

12.

Ellerbrock

, Chiasson

, Bush

et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA, 2000; 283:1031–1037.

13.

Stein

, Cunningham

, Nakazono

et al. HCSUS Consortium: Screening for cervical cancer in HIV-infected women receiving care in the United States. J AIDS, 2001; 27:463–466.

14.

Maiman

, Fruchter

, Sedlis

et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol, 1998; 68:233–239.

15.

Anderson

, Paramsothy

, Heilig

et al. HIV Epidemiology Research (HER) Study Group: Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis, 2006; 42:562–568.

16.

Duerr

, Paramsothy

, Heilig

et al. HIV Epidemiology Research Study: Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis, 2006; 42:855–861.

17.

Lillo

, Ferrari

, Veglia

et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: Effect of highly active antiretroviral therapy. J Infect Dis, 2001; 184:547–551.

18.

Minkoff

, Ahdieh

, Massad

et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS, 2001; 15:2157–2164.

19.

Keiser

, Tejada

, Wunder

et al. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV Cohort Study. J AIDS, 2006; 43:550–555.

20.

Solomon

, Stein

, Flynn

et al. Health services use by urban women with or at risk for HIV-1 infection: The HERS Study. J AIDS, 1998; 17:253–261.

21.

Cejtin

, Komaroff

, Massad

et al. Adherence to colposcopy among women with HIV infection. J AIDS, 1999; 22:247–258.

22.

Baltimore City Health Department. Ryan White Title I Office Quality Improvement Program Primary Health Care Review 2006—Data presented January 2007.

23.

National Institutes of Health Consensus Development Panel. Cervical cancer. NIH Consensus Statement, 1996; 14:1–38.

24.

Benard

, Lawson

, Eheman

, Anderson

, Helsel

. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol, 2005; 105:1323–1328.

25.

Jennings-Dozier

. Perceptual determinants of Pap test up-to-date status among minority women. Oncol Nurs Forum, 1999; 26:1327–1333.

26.

Bazargan

, Bazargan

, Farooq

, Baker

. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med, 2004; 39:465–473.

27.

Owusu

, Eve

, Cready

et al. Race and ethnic disparities in cervical cancer screening in a safety-net system. Matern Child Health J, 2005; 9:285–295.

28.

Heckman

, Somlai

, Peters

et al. Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care, 1998; 10:365–375.

29.

Cohen

, Cook

, Grey

et al. Medically eligible women who do not use HAART: The importance of abuse, drug use, and race. Am J Public Health, 2004; 94:1147–1151.

30.

Andersen

, Tinsley

, Milfort

et al. HIV health care access issues for women living with HIV, mental illness, and substance abuse. AIDS Patient Care STDs, 2005; 19:449–459.

31.

Hicks

, Mulvey

, Chander

et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care, 2007; 19:1134–1140.

32.

Hinkin

, Barclay

, Castellon

et al. Drug use and medication adherence among HIV-infected individuals. AIDS Behav, 2007; 11:185–194.

33.

Wyatt

, Carmona

, Loeb

, Williams

. HIV-positive black women with histories of childhood sexual abuse: Patterns of substance use and barriers to health care. J Health Care Poor Underserved, 2005; 16:9–23.

34.

Shapiro

, Morton

, McCaffrey

et al. Variations in the care of HIV-infected adults in the United States. JAMA, 1999; 281:2305–2315.

35.

Ojikutu

, Stone

. Women, inequality, and the burden of HIV. N Engl J Med, 2007; 352:649–652.

36.

Cunningham

, Andersen

, Katz

et al. The impact of competing subsistence needs and barriers to access to medical care for persons with HIV receiving care in the United States. Med Care, 1999; 37:1270–1281.

37.

Schuster

, Collins

, Cunningham

et al. Perceived discrimination in clinical care in a nationally representative sample of HIV-infected adults receiving health care. J Gen Intern Med, 2005; 20:807–813.

38.

Beach

, Keruly

, Moore

. Is the quality of the patient-provider relationship associated with better adherence and outcomes for patients with HIV? J Gen Intern Med, 2006; 21:661–665.

39.

Fuertes

, Mislowack

, Bennet

et al. The physician-patient working alliance. Patient Educ Couns, 2007; 66:9–36.

40.

Austin

, Ahmad

, McNally

et al. Breast and cervical cancer screening in Hispanic women: A literature review using the Health Belief Model. Womens Health Issues, 2002; 12:122–128.

41.

Byrd

, Chavez

, Wilson

. Barriers and facilitators of cervical cancer screening among Hispanic women. Ethn Dis, 2007; 17:129–134.

42.

Burak

, Myer

. Using the Health Belief Model to examine and predict college women's cervical cancer screening beliefs and behavior. Health Care Women Int, 1997; 18:251–662.